NCT06138691View on ClinicalTrials.gov

KET-RO Plus RO DBT for Treatment Resistant Depression

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 4, 2023

Primary Completion Date

January 11, 2025

Study Completion Date

February 22, 2025

Conditions
Treatment Resistant Depression
Interventions
COMBINATION_PRODUCT

Ketamine Infusion plus RO DBT

The participant will receive 4 weeks of 0.5mg/kg intravenous ketamine given over 40 minutes, as is routinely done in ketamine treatment and four months of RO DBT treatment.

Trial Locations (1)

63110-1010

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT06138691 - KET-RO Plus RO DBT for Treatment Resistant Depression | Biotech Hunter | Biotech Hunter